Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma

Mise à jour : Il y a 4 ans
Référence : NCT01753713

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This phase II trial studies how well dovitinib works in treating patients with recurrent or progressive glioblastoma. Dovitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth


Critère d'inclusion

  • Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Gliosarcoma,Recurrent Adult Brain Tumor

Liens